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Introduction
Thanks to the widespread implementation of screening proto-
cols, colorectal malignant lesions are an increasingly detected
pathology, being reported in up to 12% of resected polyps [1].
Complete endoscopic resection of rectal lesions can be
achieved with snare-polypectomy, endoscopic mucosal resec-
tion (EMR) or endoscopic submucosal dissection (ESD). How-
ever, subsequent histopathological examination of the resect-
ed specimen may reveal signs of incomplete resection raising
the need for additional treatments (▶Table 1) [2].
Limited by post-polypectomy submucosal fibrosis, a rescue
endoscopic therapy is often challenging, especially for rectal
lesions localized close to the dentate line [3]. On the other
hand, major rectal surgery often results in temporary or defi-
nitive stoma with a remarkable impact on patients reported
outcomes. In addition, post-surgical complications, such as dis-
turbed defecation, sexual and urinary dysfunctions or anasto-
Endoscopic full-thickness resection for T1 early rectal cancer:
a case series and video report
Authors
Paola Soriani1, Gian Eugenio Tontini1, Helmut Neumann2, Germana de Nucci3, Domenico De Toma4, Barbara Bruni5,
Sara Vavassori1, Luca Pastorelli1, 6, Maurizio Vecchi1, 6, Pavlos Lagoussis7
Institutions
1 Gastroenterology and Digestive Endoscopy Unit, IRCCS
Policlinico San Donato, San Donato Milanese, Milan, Italy
2 First Medical Department, University Medical Center
Mainz, Mainz, Germany
3 Gastroenterology and Digestive Endoscopy Unit,
A.O. Salvini, Garbagnate Milanese, Milan, Italy
4 Division of Oncology I, IRCCS Policlinico San Donato,
San Donato Milanese, Milan, Italy
5 Pathology and Cytodiagnostic Unit, IRCCS Policlinico
San Donato, San Donato Milanese, Milan, Italy
6 Department of Biomedical Sciences for Health,
University of Milan, Milan, Italy
7 Division of General Surgery I, IRCCS Policlinico San
Donato, San Donato Milanese, Milan, Italy
submitted 23.3.2017
accepted after revision 14.7.2017
Bibliography
DOI https://doi.org/10.1055/s-0043-118657 |
Endoscopy International Open 2017; 05: E1081–E1086
© Georg Thieme Verlag KG Stuttgart · New York
ISSN 2364-3722
Corresponding author
Gian Eugenio Tontini, MD PhD, Gastroenterology and
Digestive Endoscopy Unit, IRCCS Policlinico San Donato,
Via Morandi 30, 20097 San Donato Milanese, Milan, Italy
Fax: +39-2-52774655
gianeugeniotontini@libero.it
ABSTRACT
Background and study aims Endoscopic treatment of
malignant colorectal polyps is often challenging, especially
for early rectal cancer (ERC) localized close to the dentate
line. Conversely, the surgical approach may result in tem-
porary or definitive stoma and in frequent post-surgical
complications. The Full-Thickness Resection Device
(FTRD®) System (Ovesco Endoscopy, Tübingen, Germany)
is a novel system that, besides having other indications,
appears to be promising for wall-thickness excision of intes-
tinal T1 carcinoma following incomplete endoscopic resec-
tion. However, follow-up data on patients treated with this
device are scarce, particularly for ERC.
Patients and methods Six consecutive patients with in-
complete endoscopic resection of T1-ERC were treated
with the FTRD and their long-term outcomes were evaluat-
ed based on a detailed clinical and instrumental assess-
ment.
Results The endoscopic en bloc full-thickness resection
was technically feasible in all patients. The histopathologic
analysis showed a complete endoscopic resection in all
cases, and a full-thickness excision in four. Neither compli-
cations, nor disease recurrence were observed during the 1-
year follow-up period.
Conclusions The FTRD System is a promising tool for
treating ERC featuring a residual risk of disease recurrence
after incomplete endoscopic mucosal resection in patients
unfit for surgery or refusing a surgical approach.
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motic dehiscence, may arise from rectal surgery even in tertiary
referral centers [4, 5].
To overcome these limitations, a novel endoscopic therapeu-
tic tool, called the Full-Thickness Resection Device (FTRD®) Sys-
tem (Ovesco Endoscopy, Tübingen, Germany) has recently been
introduced. This endoscopic approach is technically successful
for intestinal T1 carcinoma following incomplete resection,
non-lifting adenoma or adenoma arising in difficult positions
(i. e. the neck of the diverticulum, appendix, and dentate line).
In selected cases, the FTRD proved effective for endoscopic
treatment of small submucosal tumors and for diagnostic pur-
poses [6–12]. The main features of this technique lie in gener-
ating a pseudopolyp involving the intestinal wall-thickness
within an endoscopic cap (diameter 13mm, length 23mm) fol-
lowed by an en bloc resection using a hot snare technique
(monofilament, 14-mm polypectomy snare preloaded in the
tip of the cap), after the deployment of a modified over-the-
scope clip (diameter 14mm) to seal the likely underlying trans-
mural defect [6–12]. The FTRD can be quickly pre-loaded on
the tip of an endoscope with a tip diameter of 11.2–13.2mm.
Initial experiences using the FTRD have shown promising re-
sults, especially in high risk patients and in lesions located in pe-
culiar anatomic sites where standard endoscopic or surgical ap-
proaches would carry considerable risks and require aggressive
strategies [6–12].
The aim of this pilot study was to assess for the first time the
feasibility and long-term clinical impact of endoscopic treat-
ment with the new FTRD in selected patients with T1-early rec-
tal cancer (ERC) following an incomplete endoscopic mucosal
excision.
Patients and methods
Consecutive patients diagnosed with T1-ERC following incom-
plete endoscopic resection or showing submucosal involve-
ment (R1) at histological examination were evaluated for endo-
scopic full-thickness resection (EFTR) after a complete oncolo-
gic work-up. The inclusion criteria were: (i) residual rectal lesion
or rectal scar < 20 mm; (ii) increased probability of disease re-
currence as defined by the histopathological evidence of > 1
criteria according to Ueno et al. [2]; (iii) no lymphatic or meta-
static disease at computed tomography (CT) scan and rectal
endoscopic ultrasound (EUS); (iv) patients defined as “unfit for
surgery” according to their underlying general condition, or
who had refused the surgical option despite having received ex-
haustive information about the natural history of the disease
and the presence of a valid surgical option. The exclusion crite-
ria were patients < 18 years old, pregnancy, severe uncontrolled
coagulopathy, and inability to provide an informed consent.
These patients were offered and accepted to undergo the EFTR
procedure, providing their informed consent. This study was
carried out in accordance with the Declaration of Helsinki adop-
ted in 1964 incorporating all later amendments.
Antibiotic prophylaxis with iv cefalosporin was administered
to all patients. Before EFTR, the target lesion was identified
under white-light endoscopic imaging and marked using the
FTRD marking probe. EFTR was performed in a standard tech-
nique [6–12] using a preloaded FTRD including a tissue anchor,
a modified 14-mm over-the-scope clip and a monofilament, 14-
mm polypectomy snare connected to a standard electrosurgi-
cal device (VIO; ERBE Elektromedizin GmbH, Tübingen, Germa-
ny; ENDO CUT® Q*, effect 3, cutting duration/interval 4/1). All
procedures were conducted by expert endoscopists with initial
experience in the use of the FTRD (less than 10 procedures)
using high-resolution endoscopes with a tip diameter of 11.2–
13.2mm and digitally recorded. After endoscopic treatment,
patient outcomes were strictly monitored performing a tailored
oncologic work-up including endoscopy, CT scan, and rectal
EUS. Two expert gastrointestinal pathologists performed the
histopathological analysis on the en bloc specimens obtained
by EFTR.
Results
From June 2015 to February 2016, six patients were consecu-
tively treated at the IRCCS Policlinico San Donato, San Donato
Milanese, Italy (5 men, mean age 63 years, range 51–78 years).
All patients had previously received a rectal EMR within the pre-
vious 1–3 months, thereby receiving the histopathological di-
agnosis of high risk malignant polyp [2] (▶Table 2). Each pa-
tient had been treated with EFTR at hospital admission and dis-
charged home within the following 24 hours. The endoscopic
full-thickness resection was technically feasible in all cases
within 8–15 minutes (15–30 minutes including lesion detec-
tion, demarcation, and FTRD assembly). No immediate or late
complications occurred. No patient reported any symptom
related to the endoscopic procedure. High resolution endo-
scopic images displaying the original rectal lesions, the EFTR
procedures, and the follow-up are reported in ▶Fig. 1. A full-
length demonstrative video was also recorded (▶Video 1).
The histopathologic analysis performed on the en bloc re-
sected specimen demonstrated a complete endoscopic resec-
tion in all patients, with the achievement of a full-thickness ex-
cision in four patients. The resected specimen included the
submucosal layer with an estimated depth ≥1000µm (1250–
3050µm) but not the muscularis propria in the two remaining
patients (▶Table2). By revising these two endoscopic charts,
no evident technical issue affecting the endoscopic procedures
has been identified.
▶ Table 1 Histopathological criteria for high risk malignant polyps
according to Ueno et al. [2].
Low tumor differentiation grade (G3)
Haggitt’s levels (pedunculated polyps): 3–4
Kikuchi's levels (sessile polyps): sm3
Width of submucosal invasion:≥4000µm
Depth of submucosal invasion:≥2000µm
Positive tumor budding
Distance from the excision margin < 1mm
Presence of vascular invasion
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During follow-up, all patients underwent an oncologic work-
up with endoscopy, CT scan, and rectal EUS every 6 months
(▶Table 2). All patients were in oncologic remission after a me-
dian follow-up of 12 months (range 12–18 months) without
any radio- or chemotherapy. One patient died from cardiac fail-
ure at the 8th month of follow-up after showing no sign of dis-
ease recurrence at the 6-month oncological work-up.
Discussion
Our series confirms that EFTR with the newly introduced FTRD
System is feasible and safe in T1-ERC. This study also shows that
EFTR is a valid option for intestinal tumor excision following in-
complete endoscopic resection in patients without evidence of
metastatic or lymphatic disease when the standard surgical op-
▶ Table 2 T1 early rectal cancer features before endoscopic mucosal resection, indications for endoscopic full-thickness resection, and follow-up.
Pa-
tient
#
Rectal
site
Endoscopic
features
before EMR
Level of in-
vasion of
each ERC
according
to the EMR
specimen
Positive Ueno’s
criteria based
on the en bloc
EMR specimen
Indication
for EFTR
Pre-EFTR
staging
based on
Endoscopy,
EUS, CT
Histology based on
the en bloc EFTR
specimens
Oncologic
follow-up
1 Distal 30mm, I s,
Kudo V,
negative
lifting sign
sm3 Tumor budding,
excision margin,
Kikuchi’s level,
width of submu-
cosal invasion
Incomplete
endoscopic
excision of
T1-ERC unfit
for surgery
(ASA IV)
T0, N0, M0 R0, full-thickness
resection; histology
negative for residual
disease
Endoscopy, EUS,
and CT negative
at 3 and 12
months; Endos-
copy and EUS
negative at
18 months
2 Distal 20mm, I sp,
Kudo IIIL,
negative
lifting sign
sm3 Tumor budding,
Haggitt’s level,
excision margin,
depth and width
of submucosal
invasion
Incomplete
endoscopic
excision of
T1-ERC refus-
ing surgery
(ASA II)
T0, N0, M0 R0, full-thickness
resection; histology
negative for residual
disease
Endoscopy,
EUS and CT neg-
ative at 6 and
12 months
3 Distal 18mm, I sp,
Kudo IIIL,
negative
lifting sign
sm3 Haggitt’s level,
excision margin,
depth and width
of submucosal
invasion
Incomplete
endoscopic
excision of
T1-ERC refus-
ing surgery
(ASA III)
T0, N0, M0 R0, complete sub-
mucosal resection
but no muscularis
propria layer in the
specimen; histology
negative for residual
disease
Endoscopy,
EUS and CT neg-
ative at 6 and
12 months
4 Proxi-
mal
6mm, I s,
Kudo V,
negative
lifting sign
sm3 Haggitt’s level,
excision margin
Incomplete
endoscopic
excision of
T1-ERC unfit
for surgery
(ASA IV)
T1, N0, M0 R0, full-thickness
resection; histology
positive for adeno-
carcinoma (sm2)
Endoscopy, EUS
and CT negative
at 6 months. Pa-
tient died from
severe cardiac
disease at the 8th
follow-up month
5 Distal 7mm, I s,
Kudo IV,
negative
lifting sign
sm1 Low tumor dif-
ferentiation
grade, excision
margin
Incomplete
endoscopic
excision of
T1-ERC unfit
for surgery
(ASA IV)
T0, N0, M0 R0, full-thickness
resection; histology
negative for residual
disease
Endoscopy,
EUS and CT neg-
ative at 6 and
12 months
6 Distal 18mm, I s,
Kudo IIIL,
negative
lifting sign
sm1 Tumor budding,
excision margin,
width of submu-
cosal invasion
Incomplete
endoscopic
excision of
T1-ERC refus-
ing surgery
(ASA III)
T0, N0 R0, complete sub-
mucosal resection
but no muscularis
propria layer in the
specimen; histology
negative for residual
disease
Endoscopy,
EUS and CT neg-
ative at 6 and
12 months
ASA, physical status classification system adopted by the American Society of Anesthesiologists; EFTR, endoscopic full-thickness resection performed with the Full-
Thickness Resection Device (FTRD®) System; EMR, endoscopic mucosal resection; ERC, early rectal cancer; EUS, endoscopic ultrasound.
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tion is contraindicated, refused by the patient or the patient is
at high risk.
The proper management of high risk malignant polyps relies
on a multidisciplinary decision-making process currently based
on the estimated risk of residual disease, as well as on several
patient-specific features such as age, general global assess-
ment, underlying morbidities, long-term prognosis, and the
patient’s wishes [13]. The proper management of T1 ERC is re-
markably influenced by the risk of lymph node micrometasta-
sis. Therefore, following the endoscopic removal of colorectal
malignant polyps, the specific risk of disease recurrence de-
pends on the histopathological identification of standardized
microscopic criteria and the nodal status [2]. The precise im-
pact of each single microscopic criterion and their interrela-
tionship is still unclear. Nonetheless, when several adverse risk
factors are present and the risk of residual disease is substantial
(> 20%), the decision-making process to undergo further surgi-
cal treatment is usually straightforward [13]. Exceptions in-
clude those patients whose comorbidities outweigh the risk of
surgery and those refusing major rectal surgery to avoid the
risk of definitive stoma. Conversely, routine follow-up without
further treatment is the best option after endoscopic removal
of very low risk (< 3%) malignant polyps [13].
Notably, margin positivity on its own does not appear to be
an independent risk factor for lymph node metastasis, with the
risk of nodal metastasis being similar in patients with and with-
out margin involvement [14]. Previous studies have clearly
shown that the risk of disease recurrence is often overestima-
ted by histopathological assessment of involved margins within
the resected specimens [15, 16]. Indeed, radical surgery for in-
complete endoscopic resection of early colon-rectal cancers
provides tumor-free specimens in up to 76% of cases, thereby
failing to improve the 2-year survival rates [17] while imposing
significant risks of immediate morbidity and long-term compli-
cations on the patient.
Consequently, we performed a full thickness endoscopic re-
section following supposedly incomplete (R1) endoscopic exci-
sion with endoscopic mucosa resection of T1-ERC in those pa-
tients either refusing or unfit for the standard surgical options.
In the present series, all but one of the specimens obtained by
EFTR showed fibrotic submucosal tissue with no dysplastic resi-
due. Within these cases, no residual or recurrent dysplastic tis-
sue was observed when performing EFTR. In the remaining pa-
tient with incomplete endoscopic excision of T1-ERC, cancer re-
currence was already evident at endoscopy.
As compared to established surgical curative treatments for
rectal cancer (i. e. lower anterior resection with total mesorec-
tal excision and abdominoperineal resection), less invasive
trans-anal full-thickness excision techniques (e. g., convention-
al trans-anal excision, trans-anal endoscopic microsurgery
(TEM), or trans-anal minimally invasive surgery (TAMIS)) have
comparable 5- and 10-year survival rates [18, 19] but clear ad-
vantages in limiting either surgery-related mortality or morbid-
ity, and the need for a permanent stoma [19]. However, by re-
ducing both the resected specimens and the mesorectal lymph
node assessment, these treatments hamper the exact disease
staging, thereby implying an increased risk of local recurrence
and missed micrometastasis [20]. In addition, following either
TEM or TAMIS, major complications have been reported in
1.5–7% of patients and conversion to laparotomy with or with-
out total mesorectal excision or temporary stoma is sometimes
necessary [21–23].
Within this context, our initial results indicate that the endo-
scopic approach with the FTRD is a valid alternative to trans-
anal full-thickness excision techniques for non-pedunculated
T1-ERC smaller than 20mm (i. e. estimated maximal size refer-
ring to the luminal diameter of the rectal naïve lesion or to the
scar following previous EMR or polypectomy), resulting in low
comorbidity, fast operating time, and anesthesiology-free pro-
cedures. These results are consistent with other recent series
showing positive outcomes when the FTRD has been used for
▶ Fig. 1 High-resolution endoscopic images. a T1-early rectal le-
sions in the six patients (1–6) before endoscopic mucosal resec-
tion. b Images taken following the endoscopic full-thickness resec-
tion procedures using the Full-Thickness Resection Device (FTRD®)
System. c Images taken at the 6-month follow-up.
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the treatment of adenomatous and early colonic cancer, includ-
ing both right- and left-sided lesions [6–12]. According to
these reports, the FTRD is technically feasible for lower gastro-
intestinal mucosal lesions up to 30mm. However, we believe
that lesions ≤20mm represent an ideal target for stiff tissues
(e. g., incomplete resections with tissue fibrotic retraction,
nonlifting naïve lesions) and angulated positions (e. g., distal
rectum, recto-sigmoid junction, colonic flexure).
When compared to ESD or EMR, EFTR has the potential to al-
low for en bloc radical endoscopic excision of T1-ERC involving
all submucosal layers, with reduced risk of bleeding, perfora-
tion, and post-polypectomy syndrome, which appear consider-
able even in referral ESD centers [24, 25]. Furthermore, ESD is
technically difficult, especially in fibrotic tissue due to previous
excisions, it is time-consuming, and requires a prolonged learn-
ing curve for inexperienced endoscopists [24]. In fact, ESD out-
comes from Western studies are substantially worse compared
with Eastern studies, thereby limiting generalizability of the re-
sults [20]. However, ESD represents the only reasonable endo-
scopic approach for superficial (sm1) T1-ERC with a diameter
exceeding 30mm (i. e. large non-pedunculated colorectal
polyps), since the use of the FTRD would not be feasible for
technical reasons (cap diameter/length 13 /23mm) [6–8],
while EMR often leads to piecemeal resection, challenging his-
topathological assessment of R0 resection, and increased risk
of incomplete excision [24].
Our positive experience with EFTR has some inherent limita-
tions. Despite being prospectively designed, the main draw-
back of this pilot study is the relatively short follow-up, which
includes patients with a full negative oncologic work-up at 6 to
18 months since the time of EFTR. Secondly, six patients are not
enough to rule out the risk of potential EFTR-related complica-
tions, such as the entrapment of other pelvic structures close to
the rectal wall; to date, such complications have never been
documented in the literature [6–12]. Finally, a complete full-
thickness rectal excision was not feasible in one-third of our pa-
tients, where the deepest submucosal layer but not the muscu-
laris propria was included in the resected specimens. A post-
hoc revision of these endoscopic procedures was not able to
identify any technical feature clearly affecting the successful
full-thickness resections in those two patients. Post-polypecto-
my fibrotic changes following previous EMR can increase the
stiffness of the rectal wall and thus impair the endoscopic suc-
tion of the deepest layers within the snare housing. In any case,
the deepest layer of the suctioned tissue remains within the
over-the-scope clip, being thereby bound to ischemic injuries
and fibrotic remodeling, thus decreasing the risk of local recur-
rence.
In conclusion, this study provides initial evidence in favor of
EFTR with the newly introduced FTRD System for rectal malig-
nant polyps featuring a medium risk of disease recurrence after
endoscopic mucosal resection in patients either unfit for sur-
gery or refusing the standard surgical approach.
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